Abstract:Background Metastasis-associated protein 1 (MTA1) has been considered as a transcriptional regulator, which is significantly related to the prognosis in various types of tumors. However, whether MTA1 is a potential prognostic index of gastrointestinal cancer (GIC) remains controversial. The current meta-analysis was performed to evaluate the role of MTA1 expression in the prediction of the clinicopathological features and survival in GIC cases. And the results of gastric cancer were verified by immunohistochemistry (IHC). Methods Eligible studies assessing the relationship between MTA1 and GIC by IHC were searched in the PubMed, Cochrane, Ovid, Web of Science and CNKI databases by various search strategies. The STATA 16.0 software was applied to gather data and to analyze the potential relationship between MTA1 and GIC. The expression level of MTA1 was examined in 80 GC samples by IHC assay. SPSS 20.0 was applied for statistical analysis, and the survival curves were calculated by the Kaplan-Meier method. The data of 95% CI was displayed as “[a-b]”. Results According to the meta-analysis, the expression level of MTA1 was tightly associated with the tumor size (OR=1.82 [1.16–2.84], P =0.009), tumor tissue differentiation (OR=1.71 [1.24–2.37], P =0.001), depth of invasion (OR=3.12 [2.55–3.83], P< 0.001), lymphatic metastasis (OR=2.99 [2.02–4.43], P <0.001), distant metastasis (OR=4.66 [1.13–19.24], P= 0.034), TNM stage (OR=4.28 [2.76–6.63], P <0.001). In addition, MTA1 played the negative effects in 1- (RR=2.48 [1.45–4.25], P =0.001), 3- (RR=1.66 [1.30–2.11], P <0.001) and 5-year (RR=1.73 [1.37–2.20], P <0.001). Study in subgroup, grouped by language and tumor type, we reached similar conclusions. Further validation by IHC yielded similar conclusions. Tumor size ( P =0.008), lymph node metastasis ( P =0.007) and distant metastasis ( P =0.023) significantly accompanied with higher expression of MAT1 in GC cases. Besides, the expression level of MTA1 was statistically significantly correlated with OS in GC cases (HR=2.061 [1.066–3.986], P =0.032), which suggested that MTA1 might be an independent prognostic marker for GC. Finally, we verified the correlation between the expression level of MTA1 and prognosis of GC in 80 GC samples. Conclusions MTA1 is tightly associated with metastasis-related factors and may constitute a promising prognostic factor of GIC.

Expression of MTA1 protein in small cell lung cancer and its correlation with chemotherapy sensitivity and prognosis

Expression of MTA1 Protein in Non-Small Cell Lung Cancer and Its Association with the Prognosis of the Disease

Expression of VEGF and Its Correlation with Prognosis of Small Cell Lung Cancer

Mta1 Downregulation Inhibits Malignant Potential in A Small Cell Lung Cancer Cell Line

Clinical Significance of Overexpression of Metastasis-Associated Gene MTA1 in Cervical Cancer and Bioinformatic Analysis of Genes Coordinately Expressed with MTA1

Expression and Significance of Metastasis-Associated Gene 1(MTA1), Vascular Endothelial Growth Factor C(VEGF-C)in Non-Small Cell Lung Cancer Using Tissue Microarray

The Expression Levels and Prognosis of Notch Family in Ten Cases of Small Cell Lung Cancer

MTA1 is Up-regulated in Colorectal Cancer and is Inversely Correlated with Lymphatic Metastasis.

Expression and Prognostic Significance of Metallothionein in Non-small Cell Lung Cancer

Expression of MTS2/p15 Gene Product and Its Clinical Significance in Primary Non-Small Cell Lung Cancer

MTA 1 , an independent prognostic factor , promotes melanoma cell invasion by induction of EMT

High Expression of SLC16A1 as a Biomarker to Predict Poor Prognosis of Urological Cancers

Low Metallothionein 1M (MT1M) is Associated with Thyroid Cancer Cell Lines Progression.

Heterogeneity of molecular subtyping and therapy-related marker expression in primary tumors and paired lymph node metastases of small cell lung cancer

The Impact of Metastasis Suppressor-1, MTSS1, on Oesophageal Squamous Cell Carcinoma and Its Clinical Significance

Expressions and relationship between MTA1 and MMP-2 in hepetocellular carcinoma tissues

Nuclear Expression of metastasis-associated Protein 1 (MTA1) is Inversely Related to Progression of Oral Squamous Cell Carcinoma in Taiwan

Correlation between small-cell lung cancer serum protein/peptides determined by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and chemotherapy efficacy

CMTM1_v17 Promotes Chemotherapy Resistance and is Associated with Poor Prognosis in Non-Small Cell Lung Cancer

CMTM1_v17 is associated with chemotherapy resistance and poor prognosis in non-small cell lung cancer

Expression and Prognostic Significance of Metastasis-Associated Protein 1 in Gastrointestinal Cancer